Latiotim

Latanoprost, the active ingredient in Latiotim, is a prostaglandin analog presented as an eye drop for ocular use. It treats open-angle glaucoma and ocular hypertension by lowering intra‑ocular pressure. GNH USA supplies Latiotim as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latiotim, a combination of a prostaglandin analog and a beta‑blocker, is used to manage conditions that involve elevated intra‑ocular pressure.

Open‑angle glaucoma: reduces intra‑ocular pressure to prevent optic‑nerve damage Ocular hypertension: lowers eye pressure to reduce risk of progression to glaucoma Secondary glaucoma (e.g., pseudoexfoliative): assists in pressure reduction when other therapies are insufficient

Latiotim may cause ocular and systemic reactions.

Common Side Effects: - Eye irritation or burning sensation - Blurred vision shortly after instillation - Redness of the conjunctiva - Increased eyelash growth

Serious or Rare Side Effects: - Severe allergic reaction (e.g., swelling, rash) - Persistent eye pain or sudden vision loss - Systemic beta‑blocker effects such as bradycardia, hypotension or bronchospasm

Before prescribing Latiotim, consider the following precautions.

Assess intra‑ocular pressure baseline: ensure appropriate target pressure is set Avoid in patients with asthma or severe chronic obstructive pulmonary disease: timolol may exacerbate bronchospasm Check for known hypersensitivity to prostaglandin analogs or timolol before use Inform patients about possible iris colour change and advise regular eye examinations Store at room temperature: keep in the original container, protect from light and moisture

Latiotim can interact with other medications; review patient medication lists.

Major Interactions (Avoid): - Non‑selective beta‑blocker antagonists (e.g., propranolol): additive systemic beta‑blockade - Monoamine oxidase inhibitors: may enhance ocular hypotensive effect - Other prostaglandin analog eye drops: risk of excessive intra‑ocular pressure lowering

Moderate Interactions (Monitor Closely): - Systemic beta‑blockers (e.g., metoprolol): monitor heart rate and blood pressure - Anticholinergic eye drops: may reduce efficacy of Latiotim - Respiratory bronchodilators: watch for bronchospasm in susceptible patients